Special Issue "Synthesis around Marine Natural Products"
QuicklinksA special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (15 December 2011)
Special Issue Editor
Guest Editor
Prof. Dr. Yoshihide Usami
Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan
E-Mail: usami@gly.oups.ac.jp
Phone: +81 726 90 1083
Fax: +81 726 90 1005
Interests: natural product; anti-cancer; bioactive; structure determination; total synthesis; chemical modification
Special Issue Information
Submission
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed Open Access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs).
Keywords
- marine natural product
- bioactive
- total synthesis
- structural assignment
- chemical transformation
- chemical modification
Published Papers (8 papers)
|
Article:
New Azaphilones, Seco-Chaetomugilins A and D, Produced by a Marine-Fish-Derived Chaetomium globosum
Mar. Drugs 2009, 7(2), 249-257; doi:10.3390/md7020249
Received: 18 May 2009; in revised form: 11 June 2009 / Accepted: 15 June 2009 / Published: 16 June 2009
Show/Hide Abstract
| Download PDF Full-text (380 KB) | Download XML Full-text |
|
Mar. Drugs 2009, 7(3), 314-330; doi:10.3390/md7030314
Received: 15 June 2009; in revised form: 7 July 2009 / Accepted: 13 July 2009 / Published: 13 July 2009
Show/Hide Abstract
| Download PDF Full-text (420 KB) | Download XML Full-text |
|
Mar. Drugs 2009, 7(4), 654-671; doi:10.3390/md7040654
Received: 2 November 2009; in revised form: 19 November 2009 / Accepted: 23 November 2009 / Published: 24 November 2009
Show/Hide Abstract
| Download PDF Full-text (333 KB) | Download XML Full-text |
|
Mar. Drugs 2009, 7(4), 705-753; doi:10.3390/md7040705
Received: 30 October 2009; in revised form: 20 November 2009 / Accepted: 26 November 2009 / Published: 27 November 2009
Show/Hide Abstract
| Download PDF Full-text (426 KB) | Download XML Full-text |
|
Mar. Drugs 2010, 8(1), 122-172; doi:10.3390/md80100122
Received: 21 December 2009; in revised form: 12 January 2010 / Accepted: 13 January 2010 / Published: 21 January 2010
Show/Hide Abstract
| Download PDF Full-text (2365 KB) | Download XML Full-text |
|
Mar. Drugs 2010, 8(3), 483-497; doi:10.3390/md8030483
Received: 21 January 2010; in revised form: 2 March 2010 / Accepted: 2 March 2010 / Published: 5 March 2010
Show/Hide Abstract
| Download PDF Full-text (390 KB) | Download XML Full-text |
|
Mar. Drugs 2010, 8(4), 835-880; doi:10.3390/md8040835
Received: 28 February 2010; in revised form: 19 March 2010 / Accepted: 22 March 2010 / Published: 25 March 2010
Show/Hide Abstract
| Download PDF Full-text (377 KB) | Download XML Full-text |
|
Mar. Drugs 2012, 10(2), 358-402; doi:10.3390/md10020358
Received: 26 December 2011; in revised form: 3 February 2012 / Accepted: 3 February 2012 / Published: 14 February 2012
Show/Hide Abstract
| Download PDF Full-text (632 KB) | Download XML Full-text |
Last update: 10 October 2012
